Real-world effectiveness of ADHD medications in amphetamine dependence and borderline personality disorder

Milja Hartikainen

•ADHD drug use in Iceland and hospitalization for new-onset psychosis or mania among adults

Ragna Kristín Guðbrandsdóttir, Engilbert Sigurðsson, Halldóra Jónsdóttir, Þorsteinn Ívar Albertsson, Oddur Ingimarsson

ADHD medications and long-term risk of cardiovascular diseases

Le Zhang, Lin Li, Pontus Andell, Miguel Garcia-Argibay, Patrick D. Quinn, Brian M. D’Onofrio, Isabell Brikell, Ralf Kuja-Halkola, Paul Lichtenstein, Kristina Johnell, Henrik Larsson, Zheng Chang

Novel trial designs to personalize antidepressant treatment

Daniel Lindqvist

Psilocybin as an antidepressant? Clinical effect and biological correlates

Johan Lundberg

Psychocotropic medication and the fetal brain

Lars Henning Pedersen

Treatment resistance in psychotic disorders.

Ingrid Melle, Isabel Kreis, Kristin Fjelnseth Wold

ImmunoPsychiatry – evidence from large-scale studies to detailed clinical studies

Michael Eriksen Benros

Add-on prednisolone vs. placebo in early psychotic disorders: Results of a pilot study.

Erik Johnsen

Studies of glial cells and synaptic markers in early stages of psychosis and clinical high-risk states

Simon Cervenka

Endocannabinoid dysregulation in psychotic disorders

Heikki Laurikainen, Reetta-Liina Armio, Lauri Tuominen, Anna Kirjavainen, Olof Solin, Merja Haaparanta-Solin, Raimo K R Salokangas, Jarmo Hietala